Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.33 USD | +2.31% | -6.99% | -27.72% |
May. 21 | Biodesix, Inc. to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting | CI |
May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.72% | 193M | |
-22.13% | 7.9B | |
+76.16% | 4.53B | |
+8.00% | 2.78B | |
-50.41% | 1.99B | |
-19.59% | 1.66B | |
-20.07% | 1.49B | |
+19.31% | 1.23B | |
-45.78% | 1.1B | |
+20.25% | 996M |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Earnings Flash (BDSX) BIODESIX Posts Q4 Revenue $14.7M